The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

11601–11625 of 11860

  • SevereFDA (Drugs)·D-033-2013·2012-10-31

    Mylan Recalls Doxazosin Tablets Due to Acetaminophen and Codeine Contamination

    Mylan Pharmaceuticals is recalling 24,331 bottles of Doxazosin Tablets, USP, 2 mg, due to cross-contamination with acetaminophen and codeine.

    Product
    Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD, 15 Garnet Street***Rx Only*** Carole Park QLD 4300, Australia*** Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.SA ***
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-017-2013·2012-10-31

    Watson Recalls Necon 1/35-28 Tablets Due to Potential Cross-Contamination

    Watson Laboratories is recalling Necon 1/35-28 tablets because certain lots may contain trace amounts of Hydrochlorothiazide (HCTZ). The recall covers 6,466 cartons distributed nationwide and in Puerto Rico.

    Product
    Necon 1/35-28 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Pharma, Inc., A subsidiary of Watson Pharmaceuticals, Inc., Corona, CA 92880…
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-022-2013·2012-10-31

    CVS Pharmacy Fiber Capsules Recalled for Possible C. Difficile Contamination

    Raritan Pharmaceuticals is recalling CVS Pharmacy Fiber Capsules due to possible C. difficile contamination found in raw materials.

    Product
    CVS Pharmacy Fiber Capsules for Regularity, Dietary Fiber Supplement, 100 Capsules per bottle, Distributed by: CVS Pharmacy, Inc., Woonsocket, RI 02895 www.cvs.com UPC 0-50428-07739-9
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-029-2013·2012-10-31

    Raritan Recalls Fiber Capsules Due to Possible C. Difficile Contamination

    Raritan Pharmaceuticals is recalling Simply Right Healthcare Fiber Capsules due to possible C. difficile contamination found in raw materials.

    Product
    Simply Right Healthcare Fiber Capsules, 100% Natural Psyllium Fiber, Fiber Supplement, Fiber Laxative for Regularity, 400 capsules per bottle, Distributed by: SAM'S West, Inc., Bentonville, AR 72716, UPC 0-78742-00524-9.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-025-2013·2012-10-31

    Raritan Recalls Up&Up Psyllium Fiber Supplement for C. Difficile Contamination

    Raritan Pharmaceuticals is recalling Up&Up Psyllium Fiber Supplement due to possible C. difficile contamination in the raw material.

    Product
    Up&Up Psyllium Fiber Supplement, 100% natural psyllium husk, Fiber Therapy for Regularity/Fiber Supplement, 160 capsules per bottle, Distributed by: Target Corp., Minneapolis, MN 55403, Made in USA, NDC 11673-059-87, UPC 3-68163-11926-8.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-032-2013·2012-10-31

    Raritan Pharmaceuticals Recalls DRxChoice Fiber Capsules Due to Microbial Contamination

    Raritan Pharmaceuticals is recalling DRxChoice Fiber Capsules due to possible C. difficile contamination found in raw materials.

    Product
    DRxChoice Fiber Capsules, 25 capsules per bottle, Psyllium Husk Fiber, Mfg. by Raritan Pharmaceuticals, East Brunswick, NJ, UPC 3-68163-11925-1.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-028-2013·2012-10-31

    Raritan Pharmaceuticals Recalls Fiber Capsules Due to Microbial Contamination

    Raritan Pharmaceuticals is recalling Berkley & Jensen Fiber Capsules due to possible C. difficile contamination found in raw materials.

    Product
    Berkley & Jensen Fiber Capsules, Fiber Laxative/Fiber Supplement, 100% Natural Psyllium Fiber, 400 capsules per bottle, Distributed by: BJWC, 25 Research Drive, Westborough, MA 01581, Made in USA, UPC 4-00016-27053-2.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-021-2013·2012-10-31

    Psyllium Fiber Supplement Recalled for Possible C. Difficile Contamination

    Raritan Pharmaceuticals is recalling Best Choice Health Care Psyllium Fiber Supplement due to possible C. difficile contamination in raw materials.

    Product
    Best Choice Health Care, Psyllium Fiber Supplement, 100% natural Psyllium Fiber Laxative, 100 capsules per bottle, Proudly Distributed by: Valu Merchandisers, Co., Kansas City, KS 06106, UPC 0-70038-63439-3
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-026-2013·2012-10-31

    Raritan Pharmaceuticals Recalls Wal-Mucil Fiber Laxative Due to Microbial Contamination

    Raritan Pharmaceuticals is recalling specific lots of Wal-Mucil fiber laxative capsules due to possible C. difficile contamination in the raw material.

    Product
    Wal-Mucil 100% Natural Fiber, 100% Natural Psyllium Seed Husk, Fiber Laxative/Supplement, a)160 capsules per bottle (item #503663), and b) 320 capsules per bottle (Item #586143), Distributed by: Walgreen Co., 200 Wilmot Road, Deerfield, IL 60015-4616, www.walgreens.com, a) UPC…
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-023-2013·2012-10-31

    Equate Fiber Therapy Recalled for Possible C. Difficile Contamination

    Raritan Pharmaceuticals is recalling Equate Fiber Therapy capsules due to possible C. difficile contamination found in raw materials.

    Product
    Equate Fiber Therapy, 100% Natural Psyllium Husk Fiber, Fiber Laxative/Fiber Supplement, 160 capsules per bottle, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 68163-119-60, UPC 6-81131-77922-7.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-004-2013·2012-10-10

    Carefusion Recalls ChloraPrep Skin Preparation Due to Sterility Failure

    Carefusion 213, LLC is recalling ChloraPrep One-Step skin preparation applicators because quarantined material failed sterility testing. The affected product was distributed in Illinois, Missouri, and New Jersey.

    Product
    ChloraPrep One-Step (2% w/v chlorhexidine gluconate and 70% v/v isopropyl alcohol) Patient Preoperative Skin Preparation, 3mL Applicators, 25 Applicators per Carton, Single Use, Latex Free, Applicator is STERILE if package is intact, NDC 54365-400-01.
    Category
    Medical Device
    Distribution
    3 states
  • CriticalFDA (Drugs)·D-1698-2012·2012-10-03

    FDA Recalls Hard Ten Days Capsules for Unapproved Sildenafil

    The FDA is recalling Hard Ten Days Capsules because they contain sildenafil, an unapproved active ingredient. Consumers should stop using the product.

    Product
    Hard Ten Days Capsule, 4500 mg, boxes of 6 packets, OTC, Developed by: American Federal International Living Creature Group and Tibet Gold Source Living Creature Engineering Limited Company, Unit 18, 55 Beijing Road Central, Lhasa, Tibet
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1700-2012·2012-10-03

    Japan Weight Loss Blue Capsules Recalled for Unapproved Sibutramine

    Vitaminbestbuy.com is recalling Japan Weight Loss Blue Capsules because they contain sibutramine, an unapproved drug ingredient.

    Product
    Japan Weight Loss Blue Capsules, 9 g (300 mg), 30 count box, Green algae lipotropic (fat dissolving) agent, OTC, Distributed by Vitaminbestbuy.com, Brewerton, NY
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1686-2012·2012-10-03

    Baxter Recalls 5% Dextrose Injection Due to Chemical Contamination

    Baxter Healthcare is recalling 5% Dextrose Injection USP in AVIVA containers due to potential trace levels of cumene hydroperoxide.

    Product
    5% Dextrose Injection USP, packaged in a) 250 mL AVIVA Container, product code 6E0062, NDC 0338-6346-02; b) 500 mL AVIVA Container, product code 6E0063, NDC 0338-6346-03; Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1697-2012·2012-10-03

    Ben Venue Recalls Vecuronium Bromide Injection Due to Particulate Matter

    Ben Venue Laboratories is recalling Vecuronium Bromide for Injection due to the presence of particulate matter.

    Product
    Vecuronium Bromide for Injection, For IV use only, 20 mg per vial, 10 x 10 mg Vials, lyophilized powder per carton, Rx Only, Mfr. By: Ben Venue Laboratories, Bedford, OH 44146: Mfg for: Bedford Labs, Bedford, OH 44146, NDC 55390-039-10.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1689-2012·2012-10-03

    Baxter Recalls 0.9% Sodium Chloride Injection Due to Chemical Contamination

    Baxter Healthcare is recalling 0.9% Sodium Chloride Injection USP in AVIVA containers due to potential trace levels of cumene hydroperoxide.

    Product
    0.9% Sodium Chloride Injection USP, packaged in a) 250 mL AVIVA Container, product code 6E1322, NDC 0338-6304-02; b) 500 mL AVIVA Container, product code 6E1323, NDC 0338-6304-03; Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1702-2012·2012-10-03

    Mylan Recalls Levetiracetam Tablets Due to Foreign Tablet Presence

    Mylan Pharmaceuticals is recalling 960 bottles of Levetiracetam 500 mg tablets because foreign tablets may have been distributed in the bottles.

    Product
    LEVETIRACETAM — LEVETIRACETAM (LEVETIRACETAM)
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1699-2012·2012-10-03

    Man King Capsules Recalled for Unapproved Sildenafil Presence

    The FDA is recalling Man King Capsules because they contain sildenafil, an unapproved active ingredient. Consumers should stop using the product.

    Product
    Man King Capsules, 2800 mg, boxes of 5 packets, OTC, Developed by: American Wanbao Pharmaceutical International Group and Hainan Wanbao Biological Engineering Co., Ltd., 27 Heping Road, Haikou, Henan Province, UPC 9 009900 0032328
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1693-2012·2012-10-03

    Actavis Recalls Fentanyl Transdermal Systems Due to Subpotent Product

    Actavis is recalling Fentanyl Transdermal Systems, 100 mcg/h, because some patches may not contain fentanyl gel. The recall covers 98,088 cartons distributed nationwide.

    Product
    Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona…
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1688-2012·2012-10-03

    Baxter Recalls 5% Dextrose and 0.45% Sodium Chloride Injection Due to Chemical Contamination

    Baxter Healthcare is recalling 5,064 containers of 5% Dextrose and 0.45% Sodium Chloride Injection USP due to potential trace levels of cumene hydroperoxide.

    Product
    5% Dextrose and 0.45% Sodium Chloride Injection USP, packaged in a 500 mL AVIVA Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA; product code 6E0173, NDC 0338-6308-03
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1674-2012·2012-09-26

    Carefusion Recalls ChloraPrep Applicators Due to Incomplete Seals

    Carefusion is recalling 67,775 ChloraPrep with Tint applicators because some units had incomplete seals, potentially compromising sterility.

    Product
    ChloraPrep with Tint, HI-Lite Orange, 3 mL Applicator, Patient Preoperative Skin Preparation, External Use Only, Sterile, product code 260415, Carefusion, Leawood, KS 66211, USA
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1679-2012·2012-09-26

    Hospira Recalls Carboplatin Injection Due to Embedded Glass Particles

    Hospira Inc. is recalling Carboplatin Injection vials because visible particles are embedded in the glass neck, posing a risk of dislodging into the solution.

    Product
    CARBOPLATIN — CARBOPLATIN (CARBOPLATIN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1681-2012·2012-09-26

    Hospira Recalls Methotrexate Injection Due to Embedded Glass Particles

    Hospira Inc. is recalling Methotrexate Injection vials because visible particles embedded in the glass neck may dislodge into the solution.

    Product
    METHOTREXATE — METHOTREXATE (METHOTREXATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1676-2012·2012-09-26

    Dukal BZK Swabs Recalled for Burkholderia cepacia Contamination

    Dukal Corporation is recalling BZK Swabs, First Aid Antiseptic, due to microbial contamination with Burkholderia cepacia. The recall covers specific lots shipped since July 2009.

    Product
    Dukal Corporation BZK Swab, First Aid Antiseptic, (Benzalkonium Chloride), 0.133% w/v, Item 854-1000 contains 1000 individually packaged swabs per box. Item 854 contains 200 individually packaged swabs per box. Packaging labeled with Dukal Corporation, Hauppauge, NY 11788…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1682-2012·2012-09-26

    Hospira Recalls Paclitaxel Injection Due to Embedded Glass Particles

    Hospira Inc. is recalling Paclitaxel Injection vials because visible particles are embedded in the glass at the neck. The particles may dislodge into the solution.

    Product
    PACLITAXEL — PACLITAXEL (PACLITAXEL)
    Category
    Drug
    Distribution
    Distributed nationwide